Duc Nguyen

Compassionate Use of Remdesivir for Patients with Severe Covid-19

Erwan L'Her, Alexander Zoufaly, Marco Massari, 2020, The New England journal of medicine.

First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020

C. Campèse, Morgane Stempfelet, D. Levy-bruhl, 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Clinical and virological data of the first cases of COVID-19 in Europe: a case series

Xavier Duval, Jean-François Timsit, Yazdan Yazdanpanah, 2020, The Lancet Infectious Diseases.

Outcomes of targeted treatment in immunocompromised patients with asymptomatic or mild COVID-19: a retrospective study

V. de Lédinghen, D. Neau, S. Pédeboscq, 2023, Scientific reports.

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

G. Canonica, T. Zander, N. Adhikari, 2021, The Lancet Respiratory Medicine.

Epidemiological and clinical characteristics of patients with monkeypox in the GeoSentinel Network: a cross-sectional study

M. Beadsworth, D. Hamer, P. Kozarsky, 2022, The Lancet. Infectious diseases.

Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives

Inserm, Shana M Augustin, C. Charpentier, 2020, Clinical Microbiology and Infection.

Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs

Mark S. Anderson, Chun Jimmie Ye, P. Gregersen, 2022, Science Immunology.